फुफ्फुसाचा कर्करोग (non-small cell)
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
कुठे जायचं
या ट्रायलसाठी भारतातील 6 हॉस्पिटल्स रुग्णांना घेत आहेत.
रजिस्ट्री सारांश (तांत्रिक)
This clinical trial is designed to assess the efficacy and safety of trastuzumab deruxtecan (T-DXd; Enhertu®) in combination with pembrolizumab versus platinum-based chemotherapy in combination with pembrolizumab in participants with no prior therapy for locally advanced unresectable or metastatic non-squamous NSCLC, whose tumors have HER2-overexpressing and PD-L1 TPS \<50% without known AGA that have locally available therapies targeting their AGAs in first-line advanced/metastatic setting.
स्पॉन्सर: दाईची सांक्यो
NCT06899126 ऑन ClinicalTrials.gov
रजिस्ट्रीवर शेवटचे अपडेट 15 Sep 2026 · आम्ही वाचले 20 Oct 2026